Saturday, August 1, 2026

North Korea’s Latest Missile Launch: What You Need to Know About the 10 Ballistic Missiles Fired

North Korea launched over ten ballistic missiles, prompting an emergency review by South Korea's Office of National Security amid joint military exercises.

“TOO LITTLE TOO LATE” The Pathetic K-Iron Dome Race Against Kim’s Ready-to-Fire Artillery

South Korea accelerates Long-Range Artillery Interception System deployment to counter North Korea's artillery threats, enhancing defense capabilities.

South Korea’s Olympic Hopes: 17 Medals Predicted, But No Splash in Swimming!

The South Korean team is projected to secure a total of 17 medals at the Paris Olympics, including 5 golds.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Radiopharmaceuticals Revolution: How Novartis’s 1.4 Billion USD Investment Transforms Cancer Treatment in South Korea

A 140 billion KRW investment by Novartis aims to enhance the radioactive pharmaceutical industry, focusing on precision medicine and Theranostics.

Depression Linked to Up to 2.4-Fold Higher Risk of Fatty Liver Disease in Young Adults, Study Finds

A South Korean study reveals young adults with depression face double the risk of fatty liver disease compared to those without.

Cancer Patients Say Long Waits, Limited Consultation Time Leave Questions Unanswered

A study reveals cancer patients face communication barriers, emotional distress, and lack of support during treatment, necessitating better care.

HLB PEP Achieves FDA Registration for Vasopressin API: What This Means for Global Markets

HLB PEP has registered Vasopressin API with the FDA, aiming for global market entry and expanding its peptide portfolio.

EuBiologics Registers EcML Adjuvant Platform With U.S. FDA Drug Master File

EuBiologics' EcML™ vaccine adjuvant platform has been registered with the FDA, enhancing immunogenicity and enabling global collaborations.

Celltrion Files for European Approval of Cosentyx Biosimilar, Targets $6.7 Billion Market

Celltrion has filed for European approval of its CT-P55 biosimilar for autoimmune diseases, aiming for early market entry and expansion.

Unlocking Precision Medicine: New Antibody Design Targets KRAS(G12D) in Cancer Cells

Researchers at KAIST developed an antibody targeting KRAS(G12D) mutation, revolutionizing cancer treatment with precise immunotherapy.

Eli Lilly’s Retatrutide: The Revolutionary Triple Hormone Treatment for Obesity – What You Need to Know

Eli Lilly's retatrutide shows promising results in Phase 3 trials, aiming for FDA approval for obesity and related conditions in 2027.

How Hanmi Pharmaceutical’s AI Platform is Revolutionizing Obesity Drug Development in 2026

Hanmi Pharmaceutical leverages AI for drug discovery, developing innovative obesity treatments and advancing to clinical trials.

Interview | “Suicides Are Falling Overall? Not Among Young People—We Need Policies That Look 20 Years Ahead”

The government's suicide prevention efforts show a decline in overall rates, but youth suicides remain a critical issue needing attention.

Blood Test Alone May Predict Chemotherapy Response and Prognosis in Lymphoma Patients

South Korean researchers discover a mechanism reducing rituximab's effectiveness in DLBCL and propose a predictive blood biomarker.

‘Dream Weight-Loss Drug’ Wegovy May Also Protect Brain Health by Reducing Risk of Adult-Onset Seizures

Semaglutide may reduce adult-onset seizure risk by 56%, suggesting a link between metabolic treatment and brain health.

Exclusive: GC Biopharma Seeks First Phase 2 Trial for Homegrown mRNA Vaccine This Week

GC Biopharma advances to Phase 2 of South Korea's mRNA vaccine program, aiming for late-stage trials after Phase 1 completion.

Patients Travel Overseas for Cell Therapies—South Korea Moves to Lower Barriers to Treatment

South Korean patients seek stem cell therapies abroad due to limited options at home, despite high costs and uncertain efficacy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.